Journal article icon

Journal article

Clinical intensity modulated proton therapy for Hodgkin lymphoma: which patients benefit the most?

Abstract:

Purpose

Radiation therapy (RT) improves control of Hodgkin lymphoma (HL), but patients who undergo RT are at risk for late effects, including cardiovascular disease and second cancers, because of radiation doses to organs at risk (OARs). Proton therapy (PT) can reduce OAR doses compared with conventional photon RT. However, access to PT is currently limited, so referrals must be appropriately selective. We aimed to identify subgroups of patients with HL who could be...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1016/j.prro.2019.01.006

Authors


More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Nuffield Department of Population Health
Sub department:
Clinical Trial Service Unit
Oxford college:
St Catherine's College
Role:
Author
ORCID:
0000-0001-8575-2145
More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Nuffield Department of Population Health
Sub department:
Clinical Trial Service Unit
Role:
Author
More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Oncology
Role:
Author
Expand authors...
Publisher:
Elsevier Publisher's website
Journal:
Practical Radiation Oncology Journal website
Volume:
9
Issue:
3
Pages:
179-187
Publication date:
2019-01-29
Acceptance date:
2019-01-16
DOI:
EISSN:
1879-8519
ISSN:
1879-8500
Pmid:
30708133
Source identifiers:
969110
Pubs id:
pubs:969110
UUID:
uuid:1b433cb9-162d-4cdb-baa0-b2f12e7ea0d5
Local pid:
pubs:969110
Deposit date:
2019-05-28

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP